Parkinson’s Disease and Homocysteine: A Community-Based Study in a Folate and Vitamin B12 Deficient Population
Background. Homocysteine (Hcy) levels were higher in patients with Parkinson’s disease (PD). This could be partially explained by levodopa treatment. Whether untreated PD patients have higher Hcy levels is contradictory. Methods. A community-based study was conducted using a two-stage approach for s...
Main Authors: | Zhang Wei, Wang Tiandong, Li Yang, Meng Huaxing, Min Guowen, Fang Yalan, Niu Xiaoyuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2016/9539836 |
Similar Items
-
Assessment of Folate Status: Measurement of Homocysteine versus Vitamin B12 and Folate
by: Houcher Bakhouche, et al.
Published: (2003-02-01) -
Vitamin B12 And Folate Deficiency In a Hospital Population
by: Wadia RS, et al.
Published: (2001-01-01) -
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease
by: Fallah Nader, et al.
Published: (2006-09-01) -
Questionable reliability of homocysteine as the metabolic marker for folate and vitamin B12 deficiency in patients with chronic obstructive pulmonary disease
by: Beletić Anđelo, et al.
Published: (2015-01-01) -
Influence of Meal on Plasma Folate and Vitamin Β12, by Three Methods - and on Vitamin B6, Homocysteine and Red Blood Cell Folate
by: Candito Mirande, et al.
Published: (2005-02-01)